2018 Berkeley Conference

A portion of this conference has been approved for 2.5 AMA PRA Category 1 Credits™. The accredited portions of this activity will be held on Friday, September 21, 2018 from 1:45PM – 4:30PM. Please see agenda for further details.

Faculty

Prof. Thomas J. Borody, MD, PhD, DSc, FRACP, FACP, FACG, AGAF – Director and Gastroenterologist, Centre for Digestive Diseases, Five Dock, Sydney, Australia; Consulting Gastroenterologist, Sydney Adventist Hospital, Wahroonga, Australia; Consulting Gastroenterologist, Strathfield Private Hospital, Strathfield, Australia; Consulting Gastroenterologist, St. Vincent’s Hospital, Sydney, Australia; Adjunct Professorship, University of Technology, Sydney, Australia.

William Chamberlin, MD – Retired Gastroenterologist with over 40 years of experience

Kathleen R. Martin, MD – Gastroenterologist, KentuckyOne Health, Lexington, KY

Harry A. Oken, MD, FACP – Private Practice, Columbia, MD; Attending Physician, Howard County General Hospital, Columbia, MD; Clinical Professor of Medicine, University of Maryland School of Medicine, Baltimore, MD.

Ira Shafran, MD, AGAF – Shafran Gastroenterology Center, Winter Park, Florida

 

CME Information

The presentational method for this activity will be Case Presentation with Learner Participation, Panel Discussion, and Lecture with Q&A.  This activity targets Medical Practitioners and Researchers.  This activity will encompass the following desirable physician attributes: Patient Care & Procedural Skills, Medical Knowledge, Professionalism, Interpersonal & Communication Skills, and Practice-Based Learning.

 

Desired Outcomes

At the conclusion of the activity, participants should be able to:

  1. Predict challenges that may arise while caring for patients who may develop unusual problems as a response to a multidrug antibiotic regimen
  2. Develop a care plan that offers treatment and support for patients with complex multisystem problems
  3. Demonstrate a greater appreciation of issues that specifically relate to the needs of female patients with Crohn’s disease, particularly in regard to reproductive issues
  4. Describe Cell-Wall-Deficient forms of mycobacteria
  5. Discuss the efficacy of treating Crohn’s Disease patients with Atypical Mycobacterial Antibiotic Therapy

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint partnership of CME Consultants and the Human Paratuberculosis Foundation.  CME Consultants is accredited by the ACCME to provide continuing medical education for physicians.

CME Consultants designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credits™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.

In accordance with the Americans with Disability Act (ADA), please contact info@humanpara.com should you require special assistance.

 

Commercial Support

We would like to acknowledge the support for our program provided by Hurraw! Balm.